| abstract |
The present invention relates generally to deoxyactagardine A and B type specific compounds. Such compounds are particularly suitable for microbial infections such as C. perfringens, C. difficile, C. tetani, and / or C. botulinum, especially C. difficile Clostridium infections, especially the colon and / or lower intestinal tract. Suitable for use in treating diarrhea associated with microbial infections as well as microbial infections. |